The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity
Author:
Funder
Wu Jieping Medical Foundation
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference83 articles.
1. Inhibitory B7-family molecules in the tumor microenvironment;Zou;Nat. Rev. Immunol.,2008
2. Immune-related adverse events associated with immune checkpoint blockade;Postow;N. Engl. J. Med.,2018
3. Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis of published data;Wang;Int. J. Cancer,2017
4. Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: a retrospective study;Parlati;J. Hepatol.,2018
5. Organ-specific immune-related adverse events associated with immune checkpoint inhibitor monotherapy versus combination therapy in cancer: a meta-analysis of randomized controlled trials;Da;Front. Pharmacol.,2020
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature;Melanoma Research;2024-04-29
2. New advances in the study of PD-1/PD-L1 inhibitors-induced liver injury;International Immunopharmacology;2024-04
3. Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities;Immuno-Oncology and Technology;2024-03
4. Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity;Clinical Liver Disease;2024-01
5. Immune Checkpoint Inhibitor-Induced Liver Injury;Seminars in Liver Disease;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3